PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
Clinical trial NCT04787341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04787341
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2025-08-07
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.